Literature DB >> 1719026

Humoral immune response of tuberculous patients against the three components of the Mycobacterium bovis BCG 85 complex separated by isoelectric focusing.

J P Van Vooren1, A Drowart, M De Cock, A Van Onckelen, M H D'Hoop, J C Yernault, C Valcke, K Huygen.   

Abstract

An isoelectric-focusing technique followed by Western blot (immunoblot) analysis was used to investigate the immunoglobulin G response of tuberculous patients against each of the three components of the Mycobacterium bovis BCG antigen 85 complex. The 85A component was stained by the tuberculous as well as the non-tuberculous sera. In contrast, the 85B and the 85C proteins of the complex were not stained by the control sera but were stained by 20 of 28 tuberculous serum samples.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719026      PMCID: PMC270329          DOI: 10.1128/jcm.29.10.2348-2350.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Evidence for three separate genes encoding the proteins of the mycobacterial antigen 85 complex.

Authors:  H G Wiker; K Sletten; S Nagai; M Harboe
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

2.  Nucleotide sequence of the 32 kDa-protein gene (antigen 85 A) of Mycobacterium bovis BCG.

Authors:  L De Wit; A de la Cuvellerie; J Ooms; J Content
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

3.  Quantitative and qualitative studies on the major extracellular antigen of Mycobacterium tuberculosis H37Rv and Mycobacterium bovis BCG.

Authors:  H G Wiker; M Harboe; S Nagai; J Bennedsen
Journal:  Am Rev Respir Dis       Date:  1990-04

4.  An ELISA for the serodiagnosis of tuberculosis using a 30,000-Da native antigen of Mycobacterium tuberculosis.

Authors:  E Sada; L E Ferguson; T M Daniel
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

Review 5.  The serodiagnosis of tuberculosis and other mycobacterial diseases by enzyme-linked immunosorbent assay.

Authors:  T M Daniel; S M Debanne
Journal:  Am Rev Respir Dis       Date:  1987-05

6.  The antigens of Mycobacterium bovis, strain BCG, studied by crossed immunoelectrophoresis: a reference system.

Authors:  O Closs; M Harboe; N H Axelsen; K Bunch-Christensen; M Magnusson
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

7.  Humoral immune response in human tuberculosis: immunoglobulins G, A, and M directed against the purified P32 protein antigen of Mycobacterium bovis bacillus Calmette-Guérin.

Authors:  M Turneer; J P Van Vooren; J De Bruyn; E Serruys; P Dierckx; J C Yernault
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

8.  Cloning and expression of the Mycobacterium bovis BCG gene for extracellular alpha antigen.

Authors:  K Matsuo; R Yamaguchi; A Yamazaki; H Tasaka; T Yamada
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

9.  Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis.

Authors:  S Nagai; H G Wiker; M Harboe; M Kinomoto
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

10.  Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG.

Authors:  J De Bruyn; K Huygen; R Bosmans; M Fauville; R Lippens; J P Van Vooren; P Falmagne; M Weckx; H G Wiker; M Harboe
Journal:  Microb Pathog       Date:  1987-05       Impact factor: 3.738

View more
  9 in total

1.  Humoral responses against the 85A and 85B antigens of Mycobacterium bovis BCG in patients with leprosy and tuberculosis.

Authors:  J P Van Vooren; A Drowart; J De Bruyn; P Launois; J Millan; E Delaporte; M Develoux; J C Yernault; K Huygen
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

2.  Purification and immunoreactivity of three components from the 30/32-kilodalton antigen 85 complex in Mycobacterium tuberculosis.

Authors:  J H Lim; J K Park; E K Jo; C H Song; D Min; Y J Song; H J Kim
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  Serodiagnostic potential of culture filtrate antigens of Mycobacterium tuberculosis.

Authors:  K M Samanich; M A Keen; V D Vissa; J D Harder; J S Spencer; J T Belisle; S Zolla-Pazner; S Laal
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

4.  Human humoral responses to antigens of Mycobacterium tuberculosis: immunodominance of high-molecular-mass antigens.

Authors:  S Laal; K M Samanich; M G Sonnenberg; S Zolla-Pazner; J M Phadtare; J T Belisle
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

5.  Identification of Mycobacterium tuberculosis antigens of high serodiagnostic value.

Authors:  Gregory C Ireton; Rena Greenwald; Hong Liang; Javan Esfandiari; Konstantin P Lyashchenko; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2010-08-18

6.  Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis.

Authors:  S D'Souza; V Rosseels; M Romano; A Tanghe; O Denis; F Jurion; N Castiglione; A Vanonckelen; K Palfliet; Kris Huygen
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

Review 7.  The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis.

Authors:  H G Wiker; M Harboe
Journal:  Microbiol Rev       Date:  1992-12

8.  Human T cell and antibody-mediated responses to the Mycobacterium tuberculosis recombinant 85A, 85B, and ESAT-6 antigens.

Authors:  Gilson C Macedo; Adriana Bozzi; Helena Rachel Weinreich; Andre Bafica; Henrique C Teixeira; Sergio C Oliveira
Journal:  Clin Dev Immunol       Date:  2010-12-29

9.  Serodiagnostic efficacy of Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex, ESAT-6, and CFP-10 in patients with active tuberculosis.

Authors:  Gavish Kumar; Pradeep Kumar Dagur; Prashant Kumar Singh; Hari Shankar; Virendra S Yadav; Vishwa M Katoch; Bharat Bajaj; Rajesh Gupta; Utpal Sengupta; Beenu Joshi
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-01-05       Impact factor: 4.291

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.